Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-27 @ 11:28 PM
Study NCT ID:
NCT01924793
Status:
COMPLETED
Last Update Posted:
2017-07-19
First Post:
2013-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection
Sponsor:
Ansun Biopharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08
Start Date Type:
None
Primary Completion Date:
2017-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-11
First Submit QC Date:
None
Study First Post Date:
2013-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-18
Last Update Post Date:
2017-07-19
Last Update Post Date Type:
ACTUAL